
Enfortumab vedotin-ejfv has transformed treatment in locally advanced and metastatic urothelial carcinoma from decades-long platinum-based chemotherapy to the new standard of care combination of antibody-drug conjugate and PD-1/PD-L1 inhibitor.

Enfortumab vedotin-ejfv has transformed treatment in locally advanced and metastatic urothelial carcinoma from decades-long platinum-based chemotherapy to the new standard of care combination of antibody-drug conjugate and PD-1/PD-L1 inhibitor.

Discover the importance of early screening for type 1 diabetes and how it can prevent life-threatening complications.

Low-dose aspirin significantly reduces heart attack, stroke, and death risks in adults with type 2 diabetes and elevated cardiovascular risk.

Oral semaglutide shows promise in enhancing glucose control and reducing cardiovascular risks.

Razumab, a ranibizumab biosimilar, shows comparable efficacy to its innovator counterpart in treating myopic choroidal neovascular membrane (mCNVM), offering a cost-effective solution.

Linaclotide has been approved to treat patients aged 7 and older with irritable bowel syndrome with constipation, becoming the first treatment for this indication in this age group.

Pharmacists enhance community health by providing accessible care, managing complex medications, and fostering trust in patient relationships.

Adults in the United States are often infected by serotypes of Streptococcus pneumoniae unique to the pneumococcal 21-valent conjugate vaccine (PCV21) compared with those unique to PCV20.

Shara Bialo, MD, emphasizes the critical role of autoantibody screening in early T1D detection, enhancing patient outcomes during American Diabetes Month.

Maternal COVID-19 infection raises concerns about neurodevelopmental disorders in children, emphasizing the need for effective fever and infection management during pregnancy.

Craig Beavers and Kyle Fischer, PharmD, BCCP, MBA, discuss key late-breaking cardiovascular trials expected at the American Heart Association’s upcoming annual meeting, exploring their clinical relevance and implications for pharmacists.

Long-term melatonin use for insomnia raises heart failure risks, highlighting the need for careful evaluation of sleep aids and underlying health issues.

Survivors of ischemic stroke had a lower risk of major adverse cardiovascular events (MACE) when achieving low levels of low-density lipoprotein cholesterol (LDL-C).

Travelers to Europe face rising risks of tick-borne encephalitis, emphasizing the critical need for vaccinations and awareness of preventive measures.

Explore the rising prevalence of diabetes in the US, its various types, and the critical role pharmacists play in patient care.

Shara Bialo, MD, emphasizes the critical role of autoantibody screening in early T1D detection, enhancing patient outcomes during American Diabetes Month.

In children and adolescents, reinfection with COVID-19 increased the risk of worsened long COVID outcomes.

Explore innovative isotretinoin strategies for acne vulgaris, balancing efficacy and tolerability to enhance patient outcomes and long-term remission.

These findings are from the WAYFINDER clinical trial and were presented at the CHEST 2025 Annual Meeting.

Teva Pharmaceuticals recalls over 580,000 bottles of prazosin due to contamination concerns, urging patients to consult healthcare providers.

A groundbreaking vaccine shows 73% efficacy against Salmonella Paratyphi A, offering hope in combating enteric fever globally.

Explore the risks of synthetic 7-hydroxymitragynine (7-OH) products and why natural leaf kratom is a safe alternative.

Berberine is increasingly used for weight management despite limited supporting evidence, emphasizing the need for pharmacist-led education, interaction monitoring, and adverse effect counseling.

Continuous glucose monitoring (CGM) significantly enhances the detection of cystic fibrosis-related diabetes, outperforming traditional methods.

Two experts discuss sessions that covered perimenopause, premature ovarian insufficiency, GLP-1–based treatments, and the health needs of Indigenous and Hispanic women.

Influenza significantly impacts agricultural workers in the Americas, highlighting urgent vaccination needs for public health and food security.

Steps must be made to preserve pharmacy access for those who need it most.

The FDA designates Stoboclo and Osenvelt as interchangeable biosimilars for denosumab, enhancing treatment options for osteoporosis and cancer-related conditions.

Low RSV vaccination rates among older adults in the US highlight missed opportunities for reducing hospitalizations and health care costs.

Explore the impact of GLP-1 medication on weight loss in menopausal women, highlighting the need for personalized treatment approaches.